Category: by subject

That’ll do it: Physics paper retracted for a “pattern that is unphysical”

j phys dLast December, we brought you the story of a math paper that was retracted because it made “no sense mathematically.” Today, we have that retraction’s cousin: A physics paper retracted because some of the data are “unphysical.”

Here’s the notice for “Room temperature ferromagnetism in pure and Co- and Fe-doped CeO2 dilute magnetic oxide: effect of oxygen vacancies and cation valence,” which was published in April 2011 in the Journal of Physics D: Applied Physics: Continue reading That’ll do it: Physics paper retracted for a “pattern that is unphysical”

Your bad: Journal yanks paper for plagiarism and duplication, and points fingers

molecules-logoHere’s a warning to would-be plagiarizers: Don’t submit to the journal Molecules unless you have no problem being called out by name when you’re busted.

Consider: The journal is retracting a paper it published earlier this year after learning that the article contained verbatim text — and lots of it — from previously published papers.

The article, “Cytotoxicity and Anti-Inflammatory Activity of ethylsulfanyltriazoloquinazolin,” was written by a group that included Amira M. Gamal-Eldeen, of the National Research Center in Cairo, Egypt. Why single out Dr. Gamal-Eldeen, you ask? Read for yourself: Continue reading Your bad: Journal yanks paper for plagiarism and duplication, and points fingers

Management prof with 12 retractions loses his license to teach

Ulrich Lichtenthaler
Ulrich Lichtenthaler

Ulrich Lichtenthaler, the management professor at the University of Mannheim who has had a dozen papers retracted, has now lost his license to teach.

The WHU-Otto Beisheim School of Management, where Lichtenthaler earned his PhD, announced the move Friday, saying (courtesy Google Translate): Continue reading Management prof with 12 retractions loses his license to teach

It’s an epidemic! Another group does the right thing, retracting neuroscience paper

jneurosciAs the bumper sticker says, “Regime change starts at home.” Seems to be the case with scientists these days.

This month we have seen commendable instances of researchers retracting papers after identifying flaws in their own data — an outbreak of integrity that has us here at Retraction Watch applauding. (We’ve even created a new category, “doing the right thing,” at the suggestion of a reader.)

Today’s feel-good story comes from the lab of Karl Svoboda, of the Howard Hughes Medical Institute’s Janelia Farm Research Campus, in Ashburn, Va. Back in June, Svoboda and his colleagues published “Whisker Dynamics Underlying Tactile Exploration,” in the Journal of Neuroscience. Here’s what the abstract had to say about the study:

Continue reading It’s an epidemic! Another group does the right thing, retracting neuroscience paper

A Cancer Cell mega-correction for highly cited researcher who retracted paper earlier this year

cancer cell 9-13MIT’s Robert Weinberg, a leading cancer researcher who retracted a Cancer Cell paper earlier this year for “inappropriate presentation” of figures, has corrected a different paper in the same journal.

Here’s the correction for “Species- and Cell Type-Specific Requirements for Cellular Transformation:”

We were apprised recently of errors made in the assembly of Figures 2B, 3A, 4A, 4B, and 5G, resulting in the incorporation of incorrect representative images in these figures. These errors occurred during the electronic assembly and have no bearing on the conclusions of the study. The corrected figures are shown below. The authors apologize for any possible confusion this might have caused.

Here’s the original Figure 2 and caption, followed by the new version (read all the way to the end of the post for more details on how this came to light): Continue reading A Cancer Cell mega-correction for highly cited researcher who retracted paper earlier this year

Doing the right thing: Researchers retract quorum sensing paper after public process

Pamela Ronald, via UC Davis
Pamela Ronald, via UC Davis

We’ll say it again: We like being able to point out when researchers stand up and do the right thing, even at personal cost.

In December 2011, Pamela C. Ronald, of the University of California, Davis, and colleagues published a paper in PLOS ONE,”Small Protein-Mediated Quorum Sensing in a Gram-Negative Bacterium.” Such quorum sensing research is a “hot topic” right now, so not surprisingly the paper caught the attention of other scientists, and the media, including the Western Farm Press. The study has been cited eight times, according to Thomson Scientific’s Web of Knowledge.

One of those scientists who took notice was Ronald’s UC Davis colleague Jonathan Eisen, who posted about the paper on his blog. That was on January 9, 2012. But if you go to that post today, you’ll see that Eisen struck through most of it, and added this comment: Continue reading Doing the right thing: Researchers retract quorum sensing paper after public process

Real problems with retracted shame and money paper revealed

sjdmLast month, we reported on a retraction in Judgment and Decision Making that said “problems were discovered with the data.” At the time, corresponding author Wen-Bin Chiou, of National Sun Yat-sen University in Taiwan, told us that a research assistant who had since left the lab hadn’t kept questionnaires used in the research, making replication impossible.

But it turns out that wasn’t the whole story of “Shame for money: Shame enhances the incentive value of economic resources,” to put it charitably. We’ve now heard from people familiar with the case and can provide a fuller account.

The problems with the paper, according to our source, Continue reading Real problems with retracted shame and money paper revealed

What happened to Joachim Boldt’s 88 papers that were supposed to be retracted?

a&amisconductcoverCHICAGO — Almost two years after editors at 18 journals agreed in March 2011 to retract 88 of former retraction record holder Joachim Boldt’s papers, 10% of them hadn’t been retracted.

That’s what Nadia Elia, Liz Wager, and Martin Tramer reported here Sunday in an abstract at the Seventh International Congress on Peer Review and Biomedical Publication. Elia and Tramer are editors at the European Journal of Anaesthesiology, while Wager is former chair of the Committee on Publication Ethics (COPE).

As of January 2013, nine of the papers hadn’t been retracted, Tramer said, while only five — all in one journal — had completely followed COPE guidelines, with adequate retraction notices, made freely available, along with  PDFs properly marked “Retracted.” From the abstract (see page 18): Continue reading What happened to Joachim Boldt’s 88 papers that were supposed to be retracted?

Papers on potential cancer drugs retracted for image manipulation

ccr 9-13A group of researchers at the Einstein College of Medicine in the Bronx, New York has retracted two papers for image manipulation.

The retraction notices for “PM02734 (Elisidepsin) Induces Caspase-Independent Cell Death Associated with Features of Autophagy, Inhibition of the Akt/mTOR Signaling Pathway, and Activation of Death-Associated Protein Kinase” and “The Phosphatase Inhibitor Menadione (Vitamin K3) Protects Cells from EGFR Inhibition by Erlotinib and Cetuximab” say the same thing: Continue reading Papers on potential cancer drugs retracted for image manipulation

Lancet retracts Jikei Heart Study of valsartan following investigation

logo_lancetThe Lancet has retracted a study of Novartis’ blood pressure drug valsartan (Diovan) that has been subject to an investigation following the retraction of a related study earlier this year.

Continue reading Lancet retracts Jikei Heart Study of valsartan following investigation